Respiratory Tract Diseases  >>  MG1109  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MG1109 / GC Biopharma
NCT01987011: Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers

Completed
3
420
RoW
MG1109, Placebo
Green Cross Corporation, Korean Center for Disease Control and Prevention
Influenza
10/13
03/14

Download Options